Immunotherapeutic approaches to HIV cure and remission
Authors:
- 3 December 2021
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Infectious Diseases
- Vol. 35 (1) , 31-41
Abstract
Purpose of review: Despite improvements in the effectiveness of antiretroviral therapy (ART), there are still unmet needs for people living with HIV which drive the search for a cure for HIV infection. The goal of this review is to discuss the challenges and recent immunotherapeutic advances towards developing a safe, effective and durable cure strategy for HIV. Recent findings: In recent years, advances have been made in uncovering the mechanisms of persistence of latent HIV and in developing more accurate assays to measure the intact proviral reservoir. Broadly neutralising antibodies and modern techniques to enhance antibody responses have shown promising results. Other strategies including therapeutic vaccination, latency reversal agents, and immunomodulatory agents have shown limited success, but newer interventions including engineered T cells and other immunotherapies may be a potent and flexible strategy for achieving HIV cure. Summary: Although progress with newer cure strategies may be encouraging, challenges remain and it is essential to achieve a high threshold of safety and effectiveness in the era of safe and effective ART. It is likely that to achieve sustained HIV remission or cure, a multipronged approach involving a combination of enhancing both adaptive and innate immunity is required.Keywords
This publication has 84 references indexed in Scilit:
- Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117Nature, 2015
- A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaquesJournal of Translational Medicine, 2015
- Quantification of HIV-1 latency reversal in resting CD4 + T cells from patients on suppressive antiretroviral therapyProceedings of the National Academy of Sciences, 2014
- Impact of HIV‐related stigma on treatment adherence: systematic review and meta‐synthesisJournal of the International AIDS Society, 2013
- Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantationBlood, 2011
- Enhanced antibody half-life improves in vivo activityNature Biotechnology, 2010
- Adaptation of HIV-1 to human leukocyte antigen class INature, 2009
- Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infectionJournal of Experimental Medicine, 2008
- Precise Identification of a Human Immunodeficiency Virus Type 1 Antigen Processing MutantJournal of Virology, 2007
- Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapyAIDS, 1999